RVs 4 MDs is connecting "frontline healthcare workers" with RV and camper owners across the country, and now globally, to give nurses, doctors, and hospital staff members a safe place to isolate away ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. OKLAHOMA CITY (KFOR) – Many doctors, nurses ...

Newsweek's "Heroes of the Pandemic" series features everyday heroes showing service, sacrifice or kindness in the time of COVID-19. Emily Phillips and her husband, Jason, live with their three ...

Inside Information: Complete remission rate in frontline HR-MDS patients rose from 28% to 43% in latest data cut, confirming the deepening of responses over time. TURKU, FI / ACCESS Newswire / August ...

Median overall survival of 13.4 months in 32 r/r MDS patients treated with bexmarilimab + azacitidine ORR of 63% and 72% observed in patients with r/r MDS (n=32) and frontline MDS patients (n=18), ...

Shattuck Labs Inc (NASDAQ:STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk ...

– Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% – – Observed 27% ...

TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers through novel immunotherapies, today announces it ...

– Observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete remission (CR)/marrow complete remission (mCR) rate of 58% and median overall ...